63 related articles for article (PubMed ID: 17094272)
21. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
[TBL] [Abstract][Full Text] [Related]
22. An informatics approach identifying markers of chemosensitivity in human cancer cell lines.
Amundson SA; Myers TG; Scudiero D; Kitada S; Reed JC; Fornace AJ
Cancer Res; 2000 Nov; 60(21):6101-10. PubMed ID: 11085534
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of novel analogues of dictyostatin.
Paterson I; Gardner NM; Poullennec KG; Wright AE
Bioorg Med Chem Lett; 2007 May; 17(9):2443-7. PubMed ID: 17336522
[TBL] [Abstract][Full Text] [Related]
24. Large-scale integration of heterogeneous pharmacogenomic data for identifying drug mechanism of action.
Luo Y; Wang S; Xiao J; Peng J
Pac Symp Biocomput; 2018; 23():44-55. PubMed ID: 29218868
[TBL] [Abstract][Full Text] [Related]
25. Ensemble gene selection by grouping for microarray data classification.
Liu H; Liu L; Zhang H
J Biomed Inform; 2010 Feb; 43(1):81-7. PubMed ID: 19699316
[TBL] [Abstract][Full Text] [Related]
26. Chemical data mining of the NCI human tumor cell line database.
Wang H; Klinginsmith J; Dong X; Lee AC; Guha R; Wu Y; Crippen GM; Wild DJ
J Chem Inf Model; 2007; 47(6):2063-76. PubMed ID: 17915856
[TBL] [Abstract][Full Text] [Related]
27. Integrative transcriptional analysis between human and mouse cancer cells provides a common set of transformation associated genes.
Balestrieri C; Vanoni M; Hautaniemi S; Alberghina L; Chiaradonna F
Biotechnol Adv; 2012; 30(1):16-29. PubMed ID: 21736933
[TBL] [Abstract][Full Text] [Related]
28. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
[TBL] [Abstract][Full Text] [Related]
30. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
[TBL] [Abstract][Full Text] [Related]
31. Selection of a novel drug-response predictor in esophageal cancer: a novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response.
Fumoto S; Shimokuni T; Tanimoto K; Hiyama K; Otani K; Ohtaki M; Hihara J; Yoshida K; Hiyama E; Noguchi T; Nishiyama M
Int J Oncol; 2008 Feb; 32(2):413-23. PubMed ID: 18202764
[TBL] [Abstract][Full Text] [Related]
32. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
[TBL] [Abstract][Full Text] [Related]
33. Semi-supervised Nonnegative Matrix Factorization for gene expression deconvolution: a case study.
Gaujoux R; Seoighe C
Infect Genet Evol; 2012 Jul; 12(5):913-21. PubMed ID: 21930246
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, evaluation of anticancer activity and COMPARE analysis of N-bis(trifluoromethyl)alkyl-N'-substituted ureas with pharmacophoric moieties.
Luzina EL; Popov AV
Eur J Med Chem; 2012 Jul; 53():364-73. PubMed ID: 22538016
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic assays for screening anticancer agents.
Baharith LA; Al-Khouli A; Raab GM
Stat Med; 2006 Jul; 25(13):2323-39. PubMed ID: 16013035
[TBL] [Abstract][Full Text] [Related]
36. Use of Quantitative Structure-Activity Relationship (QSAR) and ADMET prediction studies as screening methods for design of benzyl urea derivatives for anti-cancer activity.
Lokwani D; Bhandari S; Pujari R; Shastri P; Shelke G; Pawar V
J Enzyme Inhib Med Chem; 2011 Jun; 26(3):319-31. PubMed ID: 20846089
[TBL] [Abstract][Full Text] [Related]
37. Efficient synthesis of 6-(hetero)arylthieno[3,2-b]pyridines by Suzuki-Miyaura coupling. Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycle.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; Lima RT; Vasconcelos MH
Eur J Med Chem; 2010 Dec; 45(12):5628-34. PubMed ID: 20926160
[TBL] [Abstract][Full Text] [Related]
38. Prediction of drug efficacy for cancer treatment based on comparative analysis of chemosensitivity and gene expression data.
Wan P; Li Q; Larsen JE; Eklund AC; Parlesak A; Rigina O; Nielsen SJ; Björkling F; Jónsdóttir SÓ
Bioorg Med Chem; 2012 Jan; 20(1):167-76. PubMed ID: 22154557
[TBL] [Abstract][Full Text] [Related]
39. Preclinical antitumor activity of the oral platinum analog satraplatin.
Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines.
Onnis V; Cocco MT; Fadda R; Congiu C
Bioorg Med Chem; 2009 Sep; 17(17):6158-65. PubMed ID: 19679483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
